Wave Life Sciences
WVE
19 hedge funds and large institutions have $219M invested in Wave Life Sciences in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
63.98% more ownership
Funds ownership: 0% → 63.98% (+64%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA Capital Management
Boston,
Massachusetts
|
+$111M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.3M |
| 3 |
Redmile Group
San Francisco,
California
|
+$19M |
| 4 |
New Leaf Venture Partners
New York
|
+$12.3M |
| 5 |
Clough Capital Partners
Boston,
Massachusetts
|
+$6.16M |
Top Sellers
WVE Hedge Fund Activity: Q4 2015 in Review
19 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2015, worth a combined $219M.
Buyers outnumbered sellers: 19 funds opened new WVE positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $111M.
- 19 institutional investors held Wave Life Sciences (WVE) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $219M of Wave Life Sciences stock for Q4 2015.
- 19 funds opened new Wave Life Sciences positions in Q4 2015 and 0 closed out, a net change of +19 holders.
- The largest Wave Life Sciences buyer in Q4 2015 was RA Capital Management, an estimated $111M added.
Based on aggregated 13F filings for Q4 2015.